202 related articles for article (PubMed ID: 19025431)
1. Optimal prevention of seizures induced by high-dose busulfan.
Eberly AL; Anderson GD; Bubalo JS; McCune JS
Pharmacotherapy; 2008 Dec; 28(12):1502-10. PubMed ID: 19025431
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation.
Soni S; Skeens M; Termuhlen AM; Bajwa RP; Gross TG; Pai V
Pediatr Blood Cancer; 2012 Oct; 59(4):762-4. PubMed ID: 22378696
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.
Floeter AE; McCune JS
J Oncol Pharm Pract; 2017 Jul; 23(5):344-349. PubMed ID: 27208016
[TBL] [Abstract][Full Text] [Related]
4. Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study.
Hamidieh AA; Hamedani R; Hadjibabaie M; Amini M; Sadrai S; Ghavamzadeh A
Pediatr Hematol Oncol; 2010 Oct; 27(7):529-33. PubMed ID: 20677921
[TBL] [Abstract][Full Text] [Related]
5. Lorazepam for seizure prophylaxis during high-dose busulfan administration.
Chan KW; Mullen CA; Worth LL; Choroszy M; Koontz S; Tran H; Slopis J
Bone Marrow Transplant; 2002 Jun; 29(12):963-5. PubMed ID: 12098063
[TBL] [Abstract][Full Text] [Related]
6. Comparison of levetiracetam versus phenytoin/fosphenytoin for busulfan seizure prophylaxis at a pediatric institution.
Hughes K; Garrity L; Nelson AS; Lane A; Teusink-Cross A
Pediatr Transplant; 2021 Jun; 25(4):e14026. PubMed ID: 33894096
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam for seizures after liver transplantation.
Glass GA; Stankiewicz J; Mithoefer A; Freeman R; Bergethon PR
Neurology; 2005 Mar; 64(6):1084-5. PubMed ID: 15781837
[TBL] [Abstract][Full Text] [Related]
8. Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical data.
Carreras E; Cahn JY; Puozzo C; Kröger N; Sanz G; Buzyn A; Bacigalupo A; Vernant JP
Anticancer Res; 2010 Jul; 30(7):2977-84. PubMed ID: 20683042
[TBL] [Abstract][Full Text] [Related]
9. Limitations of oral busulfan in preparative regimen before hematopoietic stem-cell transplantation.
Kami M; Hamaki T; Maruta Y; Miyakoshi S; Mutou Y
Haematologica; 2002 Feb; 87(2):ELT10. PubMed ID: 11836187
[No Abstract] [Full Text] [Related]
10. Outdated dogma? Busulfan, seizure prophylaxis, and stem cell allografting.
Ruiz-Argüelles GJ; Gomez-Almaguer D; Steensma DP
Am J Hematol; 2012 Sep; 87(9):941. PubMed ID: 22674687
[No Abstract] [Full Text] [Related]
11. Clonazepam for seizure prophylaxis in adult patients treated with high dose busulfan.
Diaz-Carrasco MS; Olmos R; Blanquer M; Velasco J; Sánchez-Salinas A; Moraleda JM
Int J Clin Pharm; 2013 Jun; 35(3):339-43. PubMed ID: 23575621
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation.
Tsujimoto SI; Shirai R; Utano T; Osumi T; Matsumoto K; Shioda Y; Kiyotani C; Uchiyama T; Deguchi T; Terashima K; Tomizawa D; Matsumoto K; Kato M
Int J Hematol; 2020 Mar; 111(3):463-466. PubMed ID: 31863341
[TBL] [Abstract][Full Text] [Related]
13. Continuous intravenous infusion of lorazepam as seizure prophylaxis in children treated with high-dose busulfan.
Caselli D; Ziino O; Bartoli A; Santangelo G; Vanadia F; Aricò M
Bone Marrow Transplant; 2008 Jul; 42(2):135-6. PubMed ID: 18372906
[No Abstract] [Full Text] [Related]
14. Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients.
Akiyama K; Kume T; Fukaya M; Shiki I; Enami T; Tatara R; Shino M; Ikeda T
Cancer Chemother Pharmacol; 2018 Oct; 82(4):717-721. PubMed ID: 30083882
[TBL] [Abstract][Full Text] [Related]
15. Busulfan neurotoxicity and EEG abnormalities: a case report.
La Morgia C; Mondini S; Guarino M; Bonifazi F; Cirignotta F
Neurol Sci; 2004 Jun; 25(2):95-7. PubMed ID: 15221628
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant conditioning in adults and children: dose assurance with intravenous busulfan.
Fisher VL; Barnes YJ; Nuss SL
Oncol Nurs Forum; 2006 Nov; 33(2):E36-43. PubMed ID: 16518436
[TBL] [Abstract][Full Text] [Related]
17. High dose busulfan and seizures.
De La Camara R; Tomas JF; Figuera A; Berberana M; Fernandez-Rañada JM
Bone Marrow Transplant; 1991 May; 7(5):363-4. PubMed ID: 2070145
[TBL] [Abstract][Full Text] [Related]
18. Busulfan triggers epileptic seizures under levetiracetam and valproic acid therapy.
Yazal Erdem A; Azık F; Tavil B; Teber S; Tunç B; Uçkan D
Pediatr Transplant; 2014 Jun; 18(4):412-3. PubMed ID: 24645650
[No Abstract] [Full Text] [Related]
19. Minimal incidence of neurotoxicity without prophylaxis during busulfan-based conditioning regimen in patients undergoing stem cell transplantation.
Leon-Rodriguez E; Rivera-Franco MM
Int J Hematol; 2016 Dec; 104(6):644-646. PubMed ID: 27722893
[TBL] [Abstract][Full Text] [Related]
20. Oral levetiracetam for prevention of busulfan-induced seizures in adult hematopoietic cell transplant.
Chaguaceda C; Aguilera-Jiménez V; Gutierrez G; Roura J; Riu G
Int J Clin Pharm; 2020 Apr; 42(2):351-354. PubMed ID: 32026356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
